The Biden administration’s final regulation affecting the Medicare Advantage industry would come with a much lighter touch ...

Documents show Robert F. Kennedy Jr. invested in biotech companies and consulted on health care — interests he might have to ...

Patrizia Cavazzoni, leader of the FDA's Center for Drug Evaluation and Research, is leaving the agency on Jan. 18.

The changes reflect “a cultural shift” around obesity medications, said Diana Zuckerman, president of the nonprofit National ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Many new names sounded as if they’d been cooked up by a medieval monk. HIV-1 would henceforth be known as Lentivirus ...

Eli Lilly is partnering with the fabled venture capital firm Andreessen Horowitz on a new fund backed with $500 million of ...

Basic public health protections help augment our national security protections,” particularly when it comes to emerging ...

A major report on alcohol’s health effects — which will inform the 2025 Dietary Guidelines for Americans — found moderate drinkers had lower all-cause mortality, and a lower risk of death ...

STAT reporters discuss why a looming patent cliff could lead to more pharmaceutical deal-making and a new obesity startup.

Enrollment of Black and Hispanic students in medical schools dropped precipitously last year after the Supreme Court banned ...